FutuRX
Latest round
- Series B
Last raised
- May 2019
Total raised
- $20M
Investors
- 6
About FutuRX
Founded in 2014 and based in Ness Ziona, Israel, FutuRX is a biotechnology accelerator that develops novel modulators of protein degradation for cancer treatments. The company's drug modulates pathways related to proteostasis that offers an approach to the preferential targeting of cancer cells.
Who invested in FutuRX
6 investors across 1 round
See all investors in FutuRX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 29, 2019
Amount
$20M
Investors
Questions about FutuRX
Who invested in FutuRX?
FutuRX has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has FutuRX raised?
FutuRX has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did FutuRX last raise money?
FutuRX's most recent round on record is a Series B, in May 2019.
What does FutuRX do?
Founded in 2014 and based in Ness Ziona, Israel, FutuRX is a biotechnology accelerator that develops novel modulators of protein degradation for cancer treatments.
Where is FutuRX headquartered?
FutuRX is headquartered in Israel.
Which VCs invest in companies like FutuRX?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at FutuRX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like FutuRX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.